Control of cccDNA function in hepatitis B virus infection

The language of covalent histone modifications

Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679

Acetylation of Histones and Transcription-Related Factors

Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,824

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223

Hepatitis B Virus Infection: Epidemiology and Vaccination

Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,152

Cellular Memory and the Histone Code

Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142

Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection

Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆

Werle–Lapostolle, B., Bowden, S., Locarnini, S., Wursthorn, K., Petersen, J., Lau, G., Trepo, C., Marcellin, P., Goodman, Z., & Delaney IV, W. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.018 · Cited by 905

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response

Rehermann, B., Ferrari, C. I., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 850

Statements from the Taormina expert meeting on occult hepatitis B virus infection

Raimondo, G., Allain, J., Brunetto, M. R., Buendia, M., Chen, D., Colombo, M. G., Craxı̀, A., Donato, F., Ferrari, C. I., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 828

Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways

Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 684

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 4,525

Mechanisms of HBV-induced hepatocellular carcinoma

Levrero, M., & Zucman‐Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,104

Viral quasispecies evolution

Domingo, E., Sheldon, J., & Perales, C. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05023-11 · Cited by 1,009

HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B

Nassal, M. (2015) · Gut · doi:10.1136/gutjnl-2015-309809 · Cited by 932

Hepatitis B virus infection

Yuen, M., Chen, D., Dusheiko, G. M., Janssen, H. L. A., Lau, D., LOCARNINI, S. A., Peters, M. G., & Lai, C. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.35 · Cited by 867

Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma

Arzumanyan, A. L., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3449 · Cited by 818

IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

Belloni, L., Allweiss, L., Guerrieri, F., Pediconi, N., Volz, T., Pollicino, T., Petersen, J., Raimondo, G., Dandri, M., & Levrero, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58847 · Cited by 594

Update of the statements on biology and clinical impact of occult hepatitis B virus infection

Raimondo, G., Locarnini, S., Pollicino, T., Levrero, M., Zoulim, F., Lok, A. S., Allain, J.-P., Berg, T., Bertoletti, A., Brunetto, M. R., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.034 · Cited by 572

A global scientific strategy to cure hepatitis B

Revill, P. A., Chisari, F. V., Block, J. M., Dandri, M., Gehring, A. J., Guo, H., Hu, J., Kramvis, A., Lampertico, P., Janssen, H. L. A., et al. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30119-0 · Cited by 540

Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function

Belloni, L., Pollicino, T., Nicola, F. D., Guerrieri, F., Raffa, G., Fanciulli, M., Raimondo, G., & Levrero, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908365106 · Cited by 498

The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo

Lin, S.-R., Yang, H.-C., Kuo, Y.-T., Liu, C.-J., Yang, T.-Y., Sung, K.-C., Lin, Y.-Y., Wang, H.-Y., Wang, C.-C., Shen, Y.-C., et al. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.38 · Cited by 386

Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir

Hadziyannis, S. J., Sevastianos, V., Rapti, I., Vassilopoulos, D., & Hadziyannis, E. S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.039 · Cited by 348

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus

Volz, T., Allweiss, L., ́Barek, M. M., Warlich, M., Lohse, A. W., Pollok, J. M., Alexandrov, A., Urban, S., Petersen, J., Lütgehetmann, M., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.008 · Cited by 331

Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management

Chang, M., & Liaw, Y. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.033 · Cited by 295

Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications

Pollicino, T., Cacciola, I., Saffioti, F., & Raimondo, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.041 · Cited by 278

Core protein: A pleiotropic keystone in the HBV lifecycle

Zlotnick, A., Venkatakrishnan, B., Tan, Z., Lewellyn, E. B., Turner, W., & Francis, S. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.06.020 · Cited by 272

Immune Responses to HCV and Other Hepatitis Viruses

Park, S., & Rehermann, B. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.010 · Cited by 273

Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication

Dong, C., Qu, L., Wang, H., Wei, L., Dong, Y., & Xiong, S. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.03.015 · Cited by 245

Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses

Königer, C., Wingert, I., Marsmann, M., Rösler, C., Beck, J., & Nassal, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409986111 · Cited by 240

Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus

Zhen, S., Hua, L., Liu, Y.-H., Gao, L.-C., Fu, J., Wan, D.-Y., Dong, L.-H., Song, H.-F., & Gao, X. (2015) · Gene Therapy · doi:10.1038/gt.2015.2 · Cited by 215

New insight in the pathobiology of hepatitis B virus infection

Dandri, M., & LOCARNINI, S. A. (2012) · Gut · doi:10.1136/gutjnl-2012-302056 · Cited by 232

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation

Lütgehetmann, M., Mancke, L. V., Volz, T., Helbig, M., Allweiss, L., Bornscheuer, T., Pollok, J. M., Lohse, A. W., Petersen, J., Urban, S., et al. (2011) · Hepatology · doi:10.1002/hep.24758 · Cited by 229

Occult HBV infection

Raimondo, G., Caccamo, G., Filomia, R., & Pollicino, T. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0327-7 · Cited by 226

N6 -methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle

Imam, H., Khan, M. A., Gokhale, N. S., McIntyre, A. B. R., Kim, G., Jang, J. Y., Kim, S., Mason, C. E., Horner, S. M., & Siddiqui, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808319115 · Cited by 225

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases

Bloom, K., Ely, A., Mussolino, C., Cathomen, T., & Arbuthnot, P. (2013) · Molecular Therapy · doi:10.1038/mt.2013.170 · Cited by 217

Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B

Fung, J., Lai, C., Seto, W., & Yuen, M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr388 · Cited by 212

The Role of cccDNA in HBV Maintenance

Allweiss, L., & Dandri, M. (2017) · Viruses · doi:10.3390/v9060156 · Cited by 203

Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1

Zhang, X., Zhang, E., Ma, Z., Pei, R., Jiang, M., Schlaak, J., Roggendorf, M., & Lu, M. (2011) · Hepatology · doi:10.1002/hep.24195 · Cited by 201

Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance

Mak, L.-Y., Wong, D. K.-H., Pollicino, T., Raimondo, G., Hollinger, F. B., & Yuen, M.-F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.042 · Cited by 223

Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis

Tarocchi, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i33.11630 · Cited by 186

Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma

Shlomai, A., de Jong, Y. P., & Rice, C. M. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.004 · Cited by 186

Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets

Severi, T., van Malenstein, H., Verslype, C., & van Pelt, J. F. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.142 · Cited by 182

Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo

Allweiss, L., Volz, T., Giersch, K., Kah, J., Raffa, G., Petersen, J., Lohse, A. W., Beninati, C., Pollicino, T., Urban, S., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312162 · Cited by 173

Interferon and Hepatitis B: Current and Future Perspectives

Ye, J., & Chen, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.733364 · Cited by 177

Epitranscriptomics in liver disease: Basic concepts and therapeutic potential

Zhao, Z., Meng, J., Su, R. J., Zhang, J., Chen, J., Ma, X., & Xia, Q. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.009 · Cited by 166

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

Rehermann, B., & Bertoletti, A. (2014) · Hepatology · doi:10.1002/hep.27323 · Cited by 168

Global strategies are required to cure and eliminate HBV infection

Revill, P. A., Testoni, B., LOCARNINI, S. A., & Zoulim, F. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.7 · Cited by 166

The Structural Biology of Hepatitis B Virus: Form and Function

Venkatakrishnan, B., & Zlotnick, A. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042238 · Cited by 165

Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B

Lebossé, F., Testoni, B., Fresquet, J., Facchetti, F., Galmozzi, E., Fournier, M., Hervieu, V., Berthillon, P., Berby, F., Bordes, I., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.024 · Cited by 164

Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism

Oehler, N., Volz, T., Bhadra, O. D., Kah, J., Allweiss, L., Giersch, K., Bierwolf, J., Riecken, K., Pollok, J. M., Lohse, A. W., et al. (2014) · Hepatology · doi:10.1002/hep.27159 · Cited by 162

An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases

Chen, J., Zhang, W., Lin, J., Wang, F., Wu, M., Chen, C., Zheng, Y., Peng, X., Li, J., & Yuan, Z. (2014) · Molecular Therapy · doi:10.1038/mt.2013.212 · Cited by 159

Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics

Guo, J., & Guo, H. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.08.005 · Cited by 153

Occult Hepatitis B Virus Infection: An Update

Saitta, C., Pollicino, T., & Raimondo, G. (2022) · Viruses · doi:10.3390/v14071504 · Cited by 149

Hepatitis B Virus Limits Response of Human Hepatocytes to Interferon-α in Chimeric Mice

Lütgehetmann, M., Bornscheuer, T., Volz, T., Allweiss, L., Bockmann, J. H., Pollok, J. M., Lohse, A. W., Petersen, J., & Dandri, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.057 · Cited by 159

Generation of Covalently Closed Circular DNA of Hepatitis B Viruses via Intracellular Recycling Is Regulated in a Virus Specific Manner

Köck, J., Rösler, C., Zhang, J., Blum, H. E., Nassal, M., & Thoma, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001082 · Cited by 146

Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine

Lim, Y., Han, S., Heo, N., Shim, J. H., Lee, H. C., & Suh, D. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.033 · Cited by 147

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance

Yang, H., & Kao, J. (2014) · Emerging Microbes & Infections · doi:10.1038/emi.2014.64 · Cited by 142

Experimental in vitro and in vivo models for the study of human hepatitis B virus infection

Allweiss, L., & Dandri, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.012 · Cited by 134

Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B

Chang, M., Liaw, Y., & Hadziyannis, S. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13272 · Cited by 129

A 2010 update on occult hepatitis B infection

Raimondo, G., Pollicino, T., Romanò, L., & Zanetti, A. R. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.02.003 · Cited by 129

Production and Function of the Cytoplasmic Deproteinized Relaxed Circular DNA of Hepadnaviruses

Guo, H., Mao, R., Block, T. M., & Guo, J. (2009) · Journal of Virology · doi:10.1128/jvi.01921-09 · Cited by 129

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction

Sekiba, K., Otsuka, M., Ohno, M., Yamagami, M., Kishikawa, T., Suzuki, T., Ishibashi, R., Seimiya, T., Tanaka, E., & Koike, K. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.010 · Cited by 126

Hepatitis B virus and hepatitis C virus dual infection

Caccamo, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14559 · Cited by 126

HBV induced hepatocellular carcinoma and related potential immunotherapy

Jia, L., Gao, Y., He, Y., Hooper, J. D., & Yang, P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104992 · Cited by 127

HBV-Integration Studies in the Clinic: Role in the Natural History of Infection

Pollicino, T., & Caminiti, G. (2021) · Viruses · doi:10.3390/v13030368 · Cited by 121

The replication cycle of hepatitis B virus

Urban, S., Schulze, A., Dandri, M., & Petersen, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.10.031 · Cited by 119

AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication

Weber, N. D., Stone, D., Sedlak, R. H., Feelixge, H. S. D. S., Roychoudhury, P., Schiffer, J. T., Aubert, M., & Jerome, K. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097579 · Cited by 122

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus

KITAMURA, K., Que, L., Shimadu, M., Koura, M., Ishihara, Y., Wakae, K., Nakamura, T., Watashi, K., Wakita, T., & Muramatsu, M. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007124 · Cited by 119

CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X

Karimova, M., Beschorner, N., Dammermann, W., Chemnitz, J., Indenbirken, D., Bockmann, J., Grundhoff, A. T., Lüth, S., Buchholz, F., Wiesch, J. S. Z., et al. (2015) · Scientific Reports · doi:10.1038/srep13734 · Cited by 116

HBV life cycle and novel drug targets

Grimm, D. G., Thimme, R., & Blum, H. E. (2011) · Hepatology International · doi:10.1007/s12072-011-9261-3 · Cited by 114

Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis

Guerrieri, F., Belloni, L., Pediconi, N., & Levrero, M. (2013) · Seminars in Liver Disease · doi:10.1055/s-0033-1345721 · Cited by 118

Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16-1 in Hepatocytes

Wang, Y., Jiang, L., Ji, X., Yang, B., Zhang, Y., & Fu, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458158 · Cited by 113

The Hepatitis B Virus Ribonuclease H Is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes

Tavis, J. E., Cheng, X., Hu, Y., Totten, M., Cao, F., Michailidis, E., Aurora, R., Meyers, M. J., Jacobsen, E. J., Parniak, M. A., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003125 · Cited by 111

Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?

Thimme, R., & Dandri, M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.007 · Cited by 103

Optimal management of hepatitis B virus infection – EASL Special Conference

Lampertico, P., Maini, M. K., & Papatheodoridis, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.026 · Cited by 103

A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide

Kaneko, M., Watashi, K., Kamisuki, S., Matsunaga, H., Iwamoto, M., Kawai, F., Ohashi, H., Tsukuda, S., Shimura, S., Suzuki, R., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01855-15 · Cited by 104

Epigenetic modulation in chronic hepatitis B virus infection

Dandri, M. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00780-6 · Cited by 99

The Interface between Hepatitis B Virus Capsid Proteins Affects Self-Assembly, Pregenomic RNA Packaging, and Reverse Transcription

Tan, Z., Pionek, K., Unchwaniwala, N., Maguire, M. L., Loeb, D. D., & Zlotnick, A. (2015) · Journal of Virology · doi:10.1128/jvi.03545-14 · Cited by 98

Diagnostic strategy for occult hepatitis B virus infection

Ocaña, S. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1553 · Cited by 98

An Overview of Natural Plant Products in the Treatment of Hepatocellular Carcinoma

Rawat, D., Shrivastava, S., Naik, R. A., Chhonker, S. K., Mehrotra, A., & Koiri, R. K. (2018) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520618666180604085612 · Cited by 98

β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity

Hu, Y., Cheng, X., Cao, F., Huang, A., & Tavis, J. E. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.007 · Cited by 95

Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?

Takaki, A. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i7.968 · Cited by 98

DDX3 DEAD-Box RNA Helicase Is a Host Factor That Restricts Hepatitis B Virus Replication at the Transcriptional Level

Ko, C., Lee, S., Windisch, M. P., & Ryu, W. (2014) · Journal of Virology · doi:10.1128/jvi.02035-14 · Cited by 95

In Vivo Proliferation of Hepadnavirus-Infected Hepatocytes Induces Loss of Covalently Closed Circular DNA in Mice

Lütgehetmann, M., Volz, T., Köpke, A., Broja, T., Tigges, E. P., Lohse, A. W., Fuchs, E., Murray, J. M., Petersen, J., & Dandri, M. (2010) · Hepatology · doi:10.1002/hep.23611 · Cited by 93

Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): Molecular mechanisms and novel paradigms

Bréchot, C., Kremsdorf, D., Soussan, P., Pineau, P., Dejean, A., Paterlini-Bréchot, P., & Tiollais, P. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.05.001 · Cited by 92

IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome

Palumbo, G. A., Scisciani, C., Pediconi, N., Lupacchini, L., Alfalate, D., Guerrieri, F., Calvo, L., Salerno, D., Cocco, S. D., Levrero, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142599 · Cited by 92

Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals

Huang, H., Wang, J., Li, W., Chen, R., Chen, X., Zhang, F., Xu, D., & Lu, F. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.12.016 · Cited by 90

When Hepatitis B Virus Meets Interferons

Tan, G., Song, H., Xu, F., & Cheng, G. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01611 · Cited by 90

Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration

Allweiss, L., Volz, T., Lütgehetmann, M., Giersch, K., Bornscheuer, T., Lohse, A. W., Petersen, J., Ma, H., Klumpp, K., Fletcher, S. P., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.021 · Cited by 91

Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA

Liu, C., Cai, D., Zhang, L., Tang, W., Yan, R., Guo, H., & Chen, X. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.08.026 · Cited by 88

Genetic variation of occult hepatitis B virus infection

Zhu, H., Xu, L., Li, J., & Zhang, Z. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i13.3531 · Cited by 86

Occult hepatitis B infection

Pollicino, T., & Raimondo, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.036 · Cited by 85

Roadmap to functional cure of chronic hepatitis B: An expert consensus

Ning, Q., Wu, D., Wang, G., Ren, H., Gao, Z., Hu, P., Han, M., Wang, Y., Zhang, W., Lu, F., et al. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13126 · Cited by 93

Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line

He, W. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i11.1507 · Cited by 84

Tridimensional infiltration of DNA viruses into the host genome shows preferential contact with active chromatin

Moreau, P., Cournac, A., Palumbo, G. A., Marbouty, M., Mortaza, S., Thierry, A., Cairo, S., Lavigne, M., Koszul, R., & Neuveut, C. (2018) · Nature Communications · doi:10.1038/s41467-018-06739-4 · Cited by 84

Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection

Pei, Y., Wang, C., Yan, S. F., & Liu, G. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01442 · Cited by 88

A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins

Tsukuda, S., Watashi, K., Hojima, T., Isogawa, M., Iwamoto, M., Omagari, K., Suzuki, R., Aizaki, H., Kojima, S., Sugiyama, M., et al. (2016) · Hepatology · doi:10.1002/hep.28952 · Cited by 81

Aiming for cure in HBV and HDV infection

Petersen, J., Thompson, A. J. V., & Levrero, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.043 · Cited by 80

N6-Methyladenosine and Viral Infection

Dang, W., Xie, Y., Cao, P., Xin, S., Wang, J., Shen, L., Li, Y., & Lu, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00417 · Cited by 77

T-cell responses in hepatitis B and C virus infection: similarities and differences

Schmidt, J., Blum, H. E., & Thimme, R. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.14 · Cited by 82

HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA

Yan, Z., Zeng, J., Yu, Y., Xiang, K., Hu, H., Zhou, X., Gu, L., Wang, L., Zhao, J., Young, J. A. T., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.004 · Cited by 80

Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection

Liaw, Y. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0197-8 · Cited by 79

Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs

Zhang, X., Hou, J., & Lu, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00202 · Cited by 78

Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus

Isorce, N., Testoni, B., Locatelli, M., Fresquet, J., Rivoire, M. L., Luangsay, S., Zoulim, F., & Durantel, D. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.03.008 · Cited by 85

Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review

Huang, X., & Hollinger, F. B. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12222 · Cited by 75

Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines

Cheng, Z., Sun, G., Guo, W., Huang, Y., Sun, W., Zhao, F., & Hu, K. (2015) · Virologica Sinica · doi:10.1007/s12250-015-3584-5 · Cited by 74

Differential assembly of Hepatitis B Virus core protein on single- and double-stranded nucleic acid suggest the dsDNA-filled core is spring-loaded

Dhason, M. S., Wang, J. C., Hagan, M. F., & Zlotnick, A. (2012) · Virology · doi:10.1016/j.virol.2012.04.012 · Cited by 74

Hepatitis B virus X protein–elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis

Gao, Y., Feng, J., Yang, G., Zhang, S., Liu, Y., Bu, Y., Sun, M., Zhao, M., Chen, F., Zhang, W., et al. (2017) · Hepatology · doi:10.1002/hep.29316 · Cited by 74

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs

Nard, F. D. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.344 · Cited by 73

IFN-α confers epigenetic regulation of HBV cccDNA minichromosome by modulating GCN5-mediated succinylation of histone H3K79 to clear HBV cccDNA

Yuan, Y., Yuan, H., Yang, G., Yun, H., Zhao, M., Liu, Z., Zhao, L., Geng, Y., Liu, L., Wang, J., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00928-z · Cited by 73

Review Control of cccDNA function in hepatitis B virus infection q

Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M. (2009)

The Role of cccDNA in HBV Maintenance

Allweiss, L., & Dandri, M. (2017) · Viruses · doi:10.3390/v9060156 · Cited by 203

Attacking hepatitis B virus cccDNA – The holy grail to hepatitis B cure

Lucifora, J., & Protzer, U. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.009 · Cited by 196

Functional cure of hepatitis B from the perspective of hepatitis B virus covalently closed circular DNA

Chen, J. (2022) · DOAJ (DOAJ: Directory of Open Access Journals)

Regulatory mechanisms of the transcription and metabolism of hepatitis B virus covalently closed circular DNA and strategies for silencing and elimination

Wenjing, Z. (2020) · DOAJ (DOAJ: Directory of Open Access Journals)